These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21129811)

  • 1. Associations between polymorphisms in DNA repair genes and TP53 mutations in non-small cell lung cancer.
    Cho S; Kim MJ; Choi YY; Yoo SS; Lee WK; Lee EJ; Jang EJ; Bae EY; Jin G; Jeon HS; Lee SY; Cha SI; Park TI; Kim CH; Park JY
    Lung Cancer; 2011 Jul; 73(1):25-31. PubMed ID: 21129811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
    Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
    Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.
    Lind H; Ekstrøm PO; Ryberg D; Skaug V; Andreassen T; Stangeland L; Haugen A; Zienolddiny S
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2077-81. PubMed ID: 17932356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
    Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J
    Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
    Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
    Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of CYP1A1 MSPI polymorphism on the relationship between TP53 mutation and CDKN2A hypermethylation in non-small cell lung cancer.
    Tan C; Xu HY; Zhang CY; Zhang H; Chen CM; Zhang WM; Sun XY; Jin YT
    Arch Med Res; 2011 Nov; 42(8):669-76. PubMed ID: 22154617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
    de Anta JM; Jassem E; Rosell R; Martínez-Roca M; Jassem J; Martínez-López E; Monzó M; Sánchez-Hernández JJ; Moreno I; Sánchez-Céspedes M
    Oncogene; 1997 Dec; 15(24):2951-8. PubMed ID: 9416838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer.
    Landvik NE; Hart K; Skaug V; Stangeland LB; Haugen A; Zienolddiny S
    Carcinogenesis; 2009 Jul; 30(7):1186-92. PubMed ID: 19461122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TP53 mutation, allelism and survival in non-small cell lung cancer.
    Nelson HH; Wilkojmen M; Marsit CJ; Kelsey KT
    Carcinogenesis; 2005 Oct; 26(10):1770-3. PubMed ID: 15905205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
    Hu Y; McDermott MP; Ahrendt SA
    Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants in MGMT and risk of lung cancer in Southeastern Chinese: a haplotype-based analysis.
    Hu Z; Wang H; Shao M; Jin G; Sun W; Wang Y; Liu H; Wang Y; Ma H; Qian J; Jin L; Wei Q; Lu D; Huang W; Shen H
    Hum Mutat; 2007 May; 28(5):431-40. PubMed ID: 17285603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer.
    Zienolddiny S; Campa D; Lind H; Ryberg D; Skaug V; Stangeland L; Phillips DH; Canzian F; Haugen A
    Carcinogenesis; 2006 Mar; 27(3):560-7. PubMed ID: 16195237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?
    Tan XL; Nieters A; Hoffmeister M; Beckmann L; Brenner H; Chang-Claude J
    Pharmacogenet Genomics; 2007 Aug; 17(8):639-45. PubMed ID: 17622940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentially functional polymorphisms in DNA repair genes and non-small-cell lung cancer survival: a pathway-based analysis.
    Dong J; Hu Z; Shu Y; Pan S; Chen W; Wang Y; Hu L; Jiang Y; Dai J; Ma H; Jin G; Shen H
    Mol Carcinog; 2012 Jul; 51(7):546-52. PubMed ID: 21739480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer.
    Popanda O; Schattenberg T; Phong CT; Butkiewicz D; Risch A; Edler L; Kayser K; Dienemann H; Schulz V; Drings P; Bartsch H; Schmezer P
    Carcinogenesis; 2004 Dec; 25(12):2433-41. PubMed ID: 15333465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53 gene mutations of lung cancer patients in upper northern Thailand and environmental risk factors.
    Bumroongkit K; Rannala B; Traisathit P; Srikummool M; Wongchai Y; Kangwanpong D
    Cancer Genet Cytogenet; 2008 Aug; 185(1):20-7. PubMed ID: 18656689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
    Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
    Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
    Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
    Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCB1 and GST polymorphisms associated with TP53 status in breast cancer.
    Nordgard SH; Ritchie MD; Jensrud SD; Motsinger AA; Alnaes GI; Lemmon G; Berg M; Geisler S; Moore JH; Lønning PE; Børresen-Dale AL; Kristensen VN
    Pharmacogenet Genomics; 2007 Feb; 17(2):127-36. PubMed ID: 17301692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck.
    An J; Liu Z; Hu Z; Li G; Wang LE; Sturgis EM; El-Naggar AK; Spitz MR; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1633-8. PubMed ID: 17684138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.